世界中の市場調査レポートを販売！当社に無いレポートもお探しします。

レポートナンバー　0000030215

医療器具・機器

アメリカの外来手術センター市場の見通し（2028年）

Research Nester

United States Ambulatory Surgical Centers Market Outlook 2028

発刊日 2021/08/02

言語英語

体裁PDF/113ページ

ライセンス/価格113ページ

0000030215

Hard Copy
Single User License
Site License
Enterprise License

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。ハードコピーもしくはPDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

お問い合わせ
サンプル依頼

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

アメリカの外来手術センター市場は、予測期間である2021年から2028年の間に、6.9%のCAGRで成長すると予想されています。先進的な手術センターへの需要は、アメリカ全土で強くなっています。先進的な医療インフラの整備に向けた政府の積極的な取り組みにより、外来手術センターの数が増加していることは、市場成長のための様々な機会を提供しています。政府の支援や慢性疾患の増加を背景に、企業はアメリカ国内のさまざまな場所に外来手術センターを積極的に拡大しています。また、病院に比べて治療費が安いなど、外来手術センターの利点に関する認識が高まっていることも、市場の成長を後押しすると考えられます。この市場は、2019年の約300億USドルから、2028年には約330億USドルの収益を獲得すると推定されています。慢性疾患の有病率の増加、高齢者人口の増加、外来手術センターへの高額な医療費が市場の主な成長要因となっています。さらに、大手企業は多数の病院や独立型手術センターの買収・合併に力を入れています。例えば、Tenet Healthcare Corporation社は、SurgCenter Developmentから45の外来手術センターを買収する計画を発表しました。これが今後の市場成長を後押しすると推測されます。アメリカの外来手術センター市場は、タイプ別、専門分野別、所有者別、治療法別に分類されています。所有者別では、企業-医師、病院-医師、企業-病院、企業のみ、医師のみ、病院のみに分類されます。これらのうち、医師のみのサービスは、2028年までに216億USドル近い最大の市場収益を達成すると予想されます。医師は、保険会社からの償還金の減少を目の当たりにし、診断や治療を行うために外来手術センターに投資しており、これがこのセグメントの成長を後押ししていると考えられます。

アメリカの外来手術センター市場は、さらに地域別に、アメリカ西部、アメリカ北東部、アメリカ南東部、アメリカ南西部、アメリカ中西部に分かれています。西アメリカ地域の市場は、医療資源に対する政府の支出が多いために外科センターの数が多く、また、投資家に影響を与える規制環境が好転していることから、予測期間中に約8％のCAGRで成長すると予想されています。アメリカ北東部の市場は、2019年の78億9,000万USドルから、2028年には86億1,600万USドルの収益を獲得すると予測されています。

主要企業

  • TH Medical
  • AMSURG Corp. (Envision Healthcare)
  • Surgical Care Affiliates, SurgCenter
  • Regent Surgical Health
  • ASD Management
  • Ambulatory Surgical Centers of America
  • Physicians Endoscopy, LLC
  • Surgery Partners

レポート詳細

目次

U.S. Ambulatory Surgical Centre Market TOC

1. Introduction
1.1. Market Definition
1.2. Market Segmentation
1.3. Product Overview

2. Assumptions and Acronyms

3. Research Methodology
3.1. Research Process
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation

4. Executive Summary- U.S. Ambulatory Surgical Centers Market

5. Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Trends
5.4. Opportunities

6. Regulatory Landscape

7. Patient Epidemiology Analysis

8. Pricing Analysis

9. Comparative Analysis of Payer System in U.S.

10. Impact Of Covid-19 On the U.S. Ambulatory Surgical Centers Market

11. Key Market Opportunities

12. Analysis On the Number of ASCs in The United States

13. Competitive Landscape
13.1. Competitive Benchmarking of Key Players
13.2. Company Profiles
13.2.1. TH Medical
13.2.2. AMSURG Corp. (Envision Healthcare)
13.2.3. Surgical Care Affiliates
13.2.4. SurgCenter
13.2.5. Regent Surgical Health
13.2.6. ASD Management
13.2.7. Physicians Endoscopy, LLC
13.2.8. Ambulatory Surgical Centers of America
13.2.9. Surgery Partners
13.2.10. Other Prominent Players

14. U.S. Ambulatory Surgical Centers Market Outlook
14.1. Market Value (USD Million)
14.2. U.S. Ambulatory Surgical Centers Market Segmentation Analysis 2019-2028
14.2.1. By Type
14.2.1.1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
14.2.1.2. Freestanding ASCs, 2019-2028F (USD Million)
14.2.2. By Specialty
14.2.2.1. Single Specialty Centers, 2019-2028F (USD Million)
14.2.2.2. Multi-Specialty Centers, 2019-2028F (USD Million)
14.2.3. By Ownership
14.2.3.1. Corporate Physician, 2019-2028F (USD Million)
14.2.3.2. Hospital Physician, 2019-2028F (USD Million)
14.2.3.3. Corporate Hospital, 2019-2028F (USD Million)
14.2.3.4. Corporate Only, 2019-2028F (USD Million)
14.2.3.5. Physician Only, 2019-2028F (USD Million)
14.2.3.6. Hospital Only, 2019-2028F (USD Million)
14.2.4. By Treatment
14.2.4.1. Orthopedic Surgeries, 2019-2028F (USD Million)
14.2.4.1.1. Spinal Surgeries, 2019-2028F (USD Million)
14.2.4.1.2. Knee Replacement Surgeries, 2019-2028F (USD Million)
14.2.4.1.3. Joint Replacement Surgeries, 2019-2028F (USD Million)
14.2.4.1.4. Ankle Repair, 2019-2028F (USD Million)
14.2.4.1.5. Others, 2019-2028F (USD Million)
14.2.4.2. Dental, 2019-2028F (USD Million)
14.2.4.2.1. Maxillofacial Surgeries, 2019-2028F (USD Million)
14.2.4.2.2. Others, 2019-2028F (USD Million)
14.2.4.3. Ophthalmology Surgeries, 2019-2028F (USD Million)
14.2.4.3.1. Lasik, 2019-2028F (USD Million)
14.2.4.3.2. Cataract, 2019-2028F (USD Million)
14.2.4.3.3. Glaucoma Surgery, 2019-2028F (USD Million)
14.2.4.3.4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
14.2.4.3.5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
14.2.4.4. Endoscopy, 2019-2028F (USD Million)
14.2.4.5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
14.2.4.5.1. Adhesiolysis, 2019-2028F (USD Million)
14.2.4.5.2. Colposcopy, 2019-2028F (USD Million)
14.2.4.5.3. Endometrial Ablation, 2019-2028F (USD Million)
14.2.4.5.4. Cervical Biopsy, 2019-2028F (USD Million)
14.2.4.5.5. Others, 2019-2028F (USD Million)
14.2.4.6. Cardiovascular Surgeries, 2019-2028F (USD Million)
14.2.4.6.1. Aortic Surgery, 2019-2028F (USD Million)
14.2.4.6.2. Heart Valve Repair, 2019-2028F (USD Million)
14.2.4.6.3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
14.2.4.6.4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
14.2.4.6.5. Others, 2019-2028F (USD Million)
14.2.4.7. Pain Management, 2019-2028F (USD Million)
14.2.4.8. Ent Surgeries, 2019-2028F (USD Million)
14.2.4.9. Neurosurgery, 2019-2028F (USD Million)
14.2.4.10. Gastrointestinal Surgery, 2019-2028F (USD Million)
14.2.4.11. Plastic Surgery, 2019-2028F (USD Million)
14.2.4.12. Others, 2019-2028F (USD Million)

15. U.S. Ambulatory Surgical Centers Market Outlook, By Region
15.1. West U.S. Ambulatory Surgical Centers Market Segmentation Analysis
15.2. Market Value (USD Million)
15.2.1. By Type
15.2.1.1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
15.2.1.2. Freestanding ASCs, 2019-2028F (USD Million)
15.2.2. By Specialty
15.2.2.1. Single Specialty Centers, 2019-2028F (USD Million)
15.2.2.2. Multi-Specialty Centers, 2019-2028F (USD Million)
15.2.3. By Ownership
15.2.3.1. Corporate Physician, 2019-2028F (USD Million)
15.2.3.2. Hospital Physician, 2019-2028F (USD Million)
15.2.3.3. Corporate Hospital, 2019-2028F (USD Million)
15.2.3.4. Corporate Only, 2019-2028F (USD Million)
15.2.3.5. Physician Only, 2019-2028F (USD Million)
15.2.3.6. Hospital Only, 2019-2028F (USD Million)
15.2.4. By Treatment
15.2.4.1. Orthopedic Surgeries, 2019-2028F (USD Million)
15.2.4.1.1. Spinal Surgeries, 2019-2028F (USD Million)
15.2.4.1.2. Knee Replacement Surgeries, 2019-2028F (USD Million)
15.2.4.1.3. Joint Replacement Surgeries, 2019-2028F (USD Million)
15.2.4.1.4. Ankle Repair, 2019-2028F (USD Million)
15.2.4.1.5. Others, 2019-2028F (USD Million)
15.2.4.2. Dental, 2019-2028F (USD Million)
15.2.4.2.1. Maxillofacial Surgeries, 2019-2028F (USD Million)
15.2.4.2.2. Others, 2019-2028F (USD Million)
15.2.4.3. Ophthalmology Surgeries, 2019-2028F (USD Million)
15.2.4.3.1. Lasik, 2019-2028F (USD Million)
15.2.4.3.2. Cataract, 2019-2028F (USD Million)
15.2.4.3.3. Glaucoma Surgery, 2019-2028F (USD Million)
15.2.4.3.4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
15.2.4.3.5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
15.2.4.4. Endoscopy, 2019-2028F (USD Million)
15.2.4.5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
15.2.4.5.1. Adhesiolysis, 2019-2028F (USD Million)
15.2.4.5.2. Colposcopy, 2019-2028F (USD Million)
15.2.4.5.3. Endometrial Ablation, 2019-2028F (USD Million)
15.2.4.5.4. Cervical Biopsy, 2019-2028F (USD Million)
15.2.4.5.5. Others, 2019-2028F (USD Million)
15.2.4.6. Cardiovascular Surgeries, 2019-2028F (USD Million)
15.2.4.6.1. Aortic Surgery, 2019-2028F (USD Million)
15.2.4.6.2. Heart Valve Repair, 2019-2028F (USD Million)
15.2.4.6.3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
15.2.4.6.4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
15.2.4.6.5. Others, 2019-2028F (USD Million)
15.2.4.7. Pain Management, 2019-2028F (USD Million)
15.2.4.8. Ent Surgeries, 2019-2028F (USD Million)
15.2.4.9. Neurosurgery, 2019-2028F (USD Million)
15.2.4.10. Gastrointestinal Surgery, 2019-2028F (USD Million)
15.2.4.11. Plastic Surgery, 2019-2028F (USD Million)
15.2.4.12. Others, 2019-2028F (USD Million)
15.3. North East U.S. Ambulatory Surgical Centers Market Segmentation Analysis
15.4. Market Value (USD Million)
15.4.1. By Type
15.4.1.1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
15.4.1.2. Freestanding ASCs, 2019-2028F (USD Million)
15.4.2. By Specialty
15.4.2.1. Single Specialty Centers, 2019-2028F (USD Million)
15.4.2.2. Multi-Specialty Centers, 2019-2028F (USD Million)
15.4.3. By Ownership
15.4.3.1. Corporate Physician, 2019-2028F (USD Million)
15.4.3.2. Hospital Physician, 2019-2028F (USD Million)
15.4.3.3. Corporate Hospital, 2019-2028F (USD Million)
15.4.3.4. Corporate Only, 2019-2028F (USD Million)
15.4.3.5. Physician Only, 2019-2028F (USD Million)
15.4.3.6. Hospital Only, 2019-2028F (USD Million)
15.4.4. By Treatment
15.4.4.1. Orthopedic Surgeries, 2019-2028F (USD Million)
15.4.4.1.1. Spinal Surgeries, 2019-2028F (USD Million)
15.4.4.1.2. Knee Replacement Surgeries, 2019-2028F (USD Million)
15.4.4.1.3. Joint Replacement Surgeries, 2019-2028F (USD Million)
15.4.4.1.4. Ankle Repair, 2019-2028F (USD Million)
15.4.4.1.5. Others, 2019-2028F (USD Million)
15.4.4.2. Dental, 2019-2028F (USD Million)
15.4.4.2.1. Maxillofacial Surgeries, 2019-2028F (USD Million)
15.4.4.2.2. Others, 2019-2028F (USD Million)
15.4.4.3. Ophthalmology Surgeries, 2019-2028F (USD Million)
15.4.4.3.1. Lasik, 2019-2028F (USD Million)
15.4.4.3.2. Cataract, 2019-2028F (USD Million)
15.4.4.3.3. Glaucoma Surgery, 2019-2028F (USD Million)
15.4.4.3.4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
15.4.4.3.5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
15.4.4.4. Endoscopy, 2019-2028F (USD Million)
15.4.4.5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
15.4.4.5.1. Adhesiolysis, 2019-2028F (USD Million)
15.4.4.5.2. Colposcopy, 2019-2028F (USD Million)
15.4.4.5.3. Endometrial Ablation, 2019-2028F (USD Million)
15.4.4.5.4. Cervical Biopsy, 2019-2028F (USD Million)
15.4.4.5.5. Others, 2019-2028F (USD Million)
15.4.4.6. Cardiovascular Surgeries, 2019-2028F (USD Million)
15.4.4.6.1. Aortic Surgery, 2019-2028F (USD Million)
15.4.4.6.2. Heart Valve Repair, 2019-2028F (USD Million)
15.4.4.6.3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
15.4.4.6.4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
15.4.4.6.5. Others, 2019-2028F (USD Million)
15.4.4.7. Pain Management, 2019-2028F (USD Million)
15.4.4.8. Ent Surgeries, 2019-2028F (USD Million)
15.4.4.9. Neurosurgery, 2019-2028F (USD Million)
15.4.4.10. Gastrointestinal Surgery, 2019-2028F (USD Million)
15.4.4.11. Plastic Surgery, 2019-2028F (USD Million)
15.4.4.12. Others, 2019-2028F (USD Million)
15.5. South East U.S. Ambulatory Surgical Centers Market Segmentation Analysis
15.6. Market Value (USD Million)
15.6.1. By Type
15.6.1.1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
15.6.1.2. Freestanding ASCs, 2019-2028F (USD Million)
15.6.2. By Specialty
15.6.2.1. Single Specialty Centers, 2019-2028F (USD Million)
15.6.2.2. Multi-Specialty Centers, 2019-2028F (USD Million)
15.6.3. By Ownership
15.6.3.1. Corporate Physician, 2019-2028F (USD Million)
15.6.3.2. Hospital Physician, 2019-2028F (USD Million)
15.6.3.3. Corporate Hospital, 2019-2028F (USD Million)
15.6.3.4. Corporate Only, 2019-2028F (USD Million)
15.6.3.5. Physician Only, 2019-2028F (USD Million)
15.6.3.6. Hospital Only, 2019-2028F (USD Million)
15.6.4. By Treatment
15.6.4.1. Orthopedic Surgeries, 2019-2028F (USD Million)
15.6.4.1.1. Spinal Surgeries, 2019-2028F (USD Million)
15.6.4.1.2. Knee Replacement Surgeries, 2019-2028F (USD Million)
15.6.4.1.3. Joint Replacement Surgeries, 2019-2028F (USD Million)
15.6.4.1.4. Ankle Repair, 2019-2028F (USD Million)
15.6.4.1.5. Others, 2019-2028F (USD Million)
15.6.4.2. Dental, 2019-2028F (USD Million)
15.6.4.2.1. Maxillofacial Surgeries, 2019-2028F (USD Million)
15.6.4.2.2. Others, 2019-2028F (USD Million)
15.6.4.3. Ophthalmology Surgeries, 2019-2028F (USD Million)
15.6.4.3.1. Lasik, 2019-2028F (USD Million)
15.6.4.3.2. Cataract, 2019-2028F (USD Million)
15.6.4.3.3. Glaucoma Surgery, 2019-2028F (USD Million)
15.6.4.3.4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
15.6.4.3.5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
15.6.4.4. Endoscopy, 2019-2028F (USD Million)
15.6.4.5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
15.6.4.5.1. Adhesiolysis, 2019-2028F (USD Million)
15.6.4.5.2. Colposcopy, 2019-2028F (USD Million)
15.6.4.5.3. Endometrial Ablation, 2019-2028F (USD Million)
15.6.4.5.4. Cervical Biopsy, 2019-2028F (USD Million)
15.6.4.5.5. Others, 2019-2028F (USD Million)
15.6.4.6. Cardiovascular Surgeries, 2019-2028F (USD Million)
15.6.4.6.1. Aortic Surgery, 2019-2028F (USD Million)
15.6.4.6.2. Heart Valve Repair, 2019-2028F (USD Million)
15.6.4.6.3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
15.6.4.6.4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
15.6.4.6.5. Others, 2019-2028F (USD Million)
15.6.4.7. Pain Management, 2019-2028F (USD Million)
15.6.4.8. Ent Surgeries, 2019-2028F (USD Million)
15.6.4.9. Neurosurgery, 2019-2028F (USD Million)
15.6.4.10. Gastrointestinal Surgery, 2019-2028F (USD Million)
15.6.4.11. Plastic Surgery, 2019-2028F (USD Million)
15.6.4.12. Others, 2019-2028F (USD Million)
15.7. South West U.S. Ambulatory Surgical Centers Market Segmentation Analysis
15.8. Market Value (USD Million)
15.8.1. By Type
15.8.1.1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
15.8.1.2. Freestanding ASCs, 2019-2028F (USD Million)
15.8.2. By Specialty
15.8.2.1. Single Specialty Centers, 2019-2028F (USD Million)
15.8.2.2. Multi-Specialty Centers, 2019-2028F (USD Million)
15.8.3. By Ownership
15.8.3.1. Corporate Physician, 2019-2028F (USD Million)
15.8.3.2. Hospital Physician, 2019-2028F (USD Million)
15.8.3.3. Corporate Hospital, 2019-2028F (USD Million)
15.8.3.4. Corporate Only, 2019-2028F (USD Million)
15.8.3.5. Physician Only, 2019-2028F (USD Million)
15.8.3.6. Hospital Only, 2019-2028F (USD Million)
15.8.4. By Treatment
15.8.4.1. Orthopedic Surgeries, 2019-2028F (USD Million)
15.8.4.1.1. Spinal Surgeries, 2019-2028F (USD Million)
15.8.4.1.2. Knee Replacement Surgeries, 2019-2028F (USD Million)
15.8.4.1.3. Joint Replacement Surgeries, 2019-2028F (USD Million)
15.8.4.1.4. Ankle Repair, 2019-2028F (USD Million)
15.8.4.1.5. Others, 2019-2028F (USD Million)
15.8.4.2. Dental, 2019-2028F (USD Million)
15.8.4.2.1. Maxillofacial Surgeries, 2019-2028F (USD Million)
15.8.4.2.2. Others, 2019-2028F (USD Million)
15.8.4.3. Ophthalmology Surgeries, 2019-2028F (USD Million)
15.8.4.3.1. Lasik, 2019-2028F (USD Million)
15.8.4.3.2. Cataract, 2019-2028F (USD Million)
15.8.4.3.3. Glaucoma Surgery, 2019-2028F (USD Million)
15.8.4.3.4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
15.8.4.3.5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
15.8.4.4. Endoscopy, 2019-2028F (USD Million)
15.8.4.5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
15.8.4.5.1. Adhesiolysis, 2019-2028F (USD Million)
15.8.4.5.2. Colposcopy, 2019-2028F (USD Million)
15.8.4.5.3. Endometrial Ablation, 2019-2028F (USD Million)
15.8.4.5.4. Cervical Biopsy, 2019-2028F (USD Million)
15.8.4.5.5. Others, 2019-2028F (USD Million)
15.8.4.6. Cardiovascular Surgeries, 2019-2028F (USD Million)
15.8.4.6.1. Aortic Surgery, 2019-2028F (USD Million)
15.8.4.6.2. Heart Valve Repair, 2019-2028F (USD Million)
15.8.4.6.3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
15.8.4.6.4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
15.8.4.6.5. Others, 2019-2028F (USD Million)
15.8.4.7. Pain Management, 2019-2028F (USD Million)
15.8.4.8. Ent Surgeries, 2019-2028F (USD Million)
15.8.4.9. Neurosurgery, 2019-2028F (USD Million)
15.8.4.10. Gastrointestinal Surgery, 2019-2028F (USD Million)
15.8.4.11. Plastic Surgery, 2019-2028F (USD Million)
15.8.4.12. Others, 2019-2028F (USD Million)
15.9. North East U.S. Ambulatory Surgical Centers Market Segmentation Analysis
15.10. Market Value (USD Million)
15.10.1. By Type
15.10.1.1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
15.10.1.2. Freestanding ASCs, 2019-2028F (USD Million)
15.10.2. By Specialty
15.10.2.1. Single Specialty Centers, 2019-2028F (USD Million)
15.10.2.2. Multi-Specialty Centers, 2019-2028F (USD Million)
15.10.3. By Ownership
15.10.3.1. Corporate Physician, 2019-2028F (USD Million)
15.10.3.2. Hospital Physician, 2019-2028F (USD Million)
15.10.3.3. Corporate Hospital, 2019-2028F (USD Million)
15.10.3.4. Corporate Only, 2019-2028F (USD Million)
15.10.3.5. Physician Only, 2019-2028F (USD Million)
15.10.3.6. Hospital Only, 2019-2028F (USD Million)
15.10.4. By Treatment
15.10.4.1. Orthopedic Surgeries, 2019-2028F (USD Million)
15.10.4.1.1. Spinal Surgeries, 2019-2028F (USD Million)
15.10.4.1.2. Knee Replacement Surgeries, 2019-2028F (USD Million)
15.10.4.1.3. Joint Replacement Surgeries, 2019-2028F (USD Million)
15.10.4.1.4. Ankle Repair, 2019-2028F (USD Million)
15.10.4.1.5. Others, 2019-2028F (USD Million)
15.10.4.2. Dental, 2019-2028F (USD Million)
15.10.4.2.1. Maxillofacial Surgeries, 2019-2028F (USD Million)
15.10.4.2.2. Others, 2019-2028F (USD Million)
15.10.4.3. Ophthalmology Surgeries, 2019-2028F (USD Million)
15.10.4.3.1. Lasik, 2019-2028F (USD Million)
15.10.4.3.2. Cataract, 2019-2028F (USD Million)
15.10.4.3.3. Glaucoma Surgery, 2019-2028F (USD Million)
15.10.4.3.4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
15.10.4.3.5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
15.10.4.4. Endoscopy, 2019-2028F (USD Million)
15.10.4.5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
15.10.4.5.1. Adhesiolysis, 2019-2028F (USD Million)
15.10.4.5.2. Colposcopy, 2019-2028F (USD Million)
15.10.4.5.3. Endometrial Ablation, 2019-2028F (USD Million)
15.10.4.5.4. Cervical Biopsy, 2019-2028F (USD Million)
15.10.4.5.5. Others, 2019-2028F (USD Million)
15.10.4.6. Cardiovascular Surgeries, 2019-2028F (USD Million)
15.10.4.6.1. Aortic Surgery, 2019-2028F (USD Million)
15.10.4.6.2. Heart Valve Repair, 2019-2028F (USD Million)
15.10.4.6.3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
15.10.4.6.4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
15.10.4.6.5. Others, 2019-2028F (USD Million)
15.10.4.7. Pain Management, 2019-2028F (USD Million)
15.10.4.8. Ent Surgeries, 2019-2028F (USD Million)
15.10.4.9. Neurosurgery, 2019-2028F (USD Million)
15.10.4.10. Gastrointestinal Surgery, 2019-2028F (USD Million)
15.10.4.11. Plastic Surgery, 2019-2028F (USD Million)
15.10.4.12. Others, 2019-2028F (USD Million)

お買い物ガイド
よくある質問

この商品のレポートナンバー

0000030215

会員登録
TOP